Because homotypic interaction is a mode of action of SLAMF7, the expression of SLAMF7 on both macrophages and some high-risk neuroblastoma cells supports the idea that SLAMF7 is a potential therapeutic target for killing the tumor cells. Here, SLAMF7 is linked to neuroblastoma.